Published in Brain on July 01, 2000
IVIG Treatment for Refractory Immune-Related Adult Epilepsy | NCT01545518
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol (2010) 7.97
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol (2005) 5.89
Immune surveillance of tumors. J Clin Invest (2007) 5.04
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
Paraneoplastic syndromes of the CNS. Lancet Neurol (2008) 4.62
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11
Rapidly progressive dementia. Ann Neurol (2008) 3.00
A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol (2016) 2.86
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry (2006) 2.52
Paraneoplastic limbic encephalitis in a teenage girl with an immature ovarian teratoma. Pediatr Radiol (2005) 2.34
Paraneoplastic neurological syndromes. Orphanet J Rare Dis (2007) 2.32
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27
Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry (2012) 2.21
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry (2007) 2.10
GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology (2011) 1.71
Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65
Serial MRI of limbic encephalitis. Neuroradiology (2006) 1.63
Rapidly progressive dementia. Neurol Clin (2007) 1.58
Autoimmune encephalitis in children. J Child Neurol (2012) 1.53
Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol (2013) 1.42
Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses. J Neurol (2005) 1.36
Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology (2010) 1.30
Paraneoplastic neurological syndromes. Curr Opin Neurol (2012) 1.29
Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol (2014) 1.25
Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry (2006) 1.22
Young onset dementia. Postgrad Med J (2004) 1.20
MRI of neurosyphilis presenting as mesiotemporal abnormalities: a case report. Korean J Radiol (2009) 1.17
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry (2012) 1.17
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci (2010) 1.13
Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol (2014) 1.13
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry (2004) 1.11
Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood (2014) 1.06
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies. Neurotherapeutics (2016) 1.02
Autoimmune-mediated encephalitis. Neuroradiology (2011) 1.01
Physical characterization of the "immunosignaturing effect". Mol Cell Proteomics (2012) 1.00
Hodgkin's Lymphoma: A Review of Neurologic Complications. Adv Hematol (2010) 0.97
Are onconeural antibodies a clinical phenomenology in paraneoplastic limbic encephalitis? Mediators Inflamm (2013) 0.96
Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am (2006) 0.96
Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience. J Neurol (2011) 0.96
Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One (2015) 0.96
Paraneoplastic limbic encephalitis presenting as a neurological emergency: a case report. J Med Case Rep (2010) 0.96
Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94
Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil. J Neurol (2010) 0.94
Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci (2005) 0.93
Limbic encephalitis: extension of the diagnostic armamentarium. J Neurol Neurosurg Psychiatry (2006) 0.91
Update on neurological paraneoplastic syndromes. Curr Opin Oncol (2015) 0.90
Paraneoplastic encephalitis associated with thymoma: a case report. Korean J Thorac Cardiovasc Surg (2013) 0.90
Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases. Orphanet J Rare Dis (2014) 0.89
Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg Psychiatry (2007) 0.89
Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality. J Neurol (2008) 0.89
Elevated antimeasles antibody titre: An association in autoimmune encephalitis. J Neurosci Rural Pract (2016) 0.89
Progressive limbic encephalopathy: Problems and prospects. Ann Indian Acad Neurol (2014) 0.88
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol (2012) 0.87
Anti-NMDA encephalitis: an uncommon, autoimmune mediated form of encephalitis. J Radiol Case Rep (2014) 0.87
Pancreatic cancer and depression: myth and truth. BMC Cancer (2010) 0.86
Autoimmune epilepsies. Neurotherapeutics (2014) 0.86
Anti-NMDAR limbic encephalitis--a clinical curiosity. World J Surg Oncol (2014) 0.85
Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: Case report and discussion. Am J Case Rep (2013) 0.84
Paraneoplastic limbic encephalitis in an elderly patient with small cell lung carcinoma. Ulster Med J (2010) 0.83
Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF. Neurology (2013) 0.83
Dementia syndromes: evaluation and treatment. Expert Rev Neurother (2007) 0.83
Autoimmune synaptopathies. Nat Rev Neurosci (2016) 0.82
Anti-Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung. J Neurol (2005) 0.82
Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol (2014) 0.82
A case of paraneoplastic limbic encephalitis associated with small cell lung cancer. Tuberc Respir Dis (Seoul) (2012) 0.81
Voltage-gated potassium channel antibody-related encephalopathy: a case which may extend the documented phenotype of this condition. BMJ Case Rep (2012) 0.81
GAD65 Positive Autoimmune Limbic Encephalitis: A Case Report and Review of Literature. J Clin Med Res (2012) 0.81
Paraneoplastic limbic encephalitis cured with resection of an adnexal mass. JSLS (2009) 0.80
Progress in the management of paraneoplastic neurological disorders. Ther Adv Neurol Disord (2010) 0.80
Rapid-eye-movement sleep behavior disorder secondary to acute aseptic limbic encephalitis. J Neurol (2009) 0.80
Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome. Eur J Med Res (2009) 0.79
Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome? BMJ Case Rep (2009) 0.79
Anti-amphiphysin associated limbic encephalitis: a paraneoplastic presentation of small-cell lung carcinoma. J Neurol (2002) 0.78
Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol (2016) 0.78
PET/CT in the evaluation of anti-NMDA-receptor encephalitis: What we need to know as a NM physician. Indian J Nucl Med (2011) 0.77
Paraneoplastic limbic encephalitis presenting as lingual epilepsia partialis continua. J Neurol (2005) 0.77
Bilateral temporal lobe disease: looking beyond herpes encephalitis. Insights Imaging (2016) 0.77
Renal Cell Carcinoma Presenting with Paraneoplastic Hallucinations and Cognitive Decline from Limbic Encephalitis. J Gen Intern Med (2015) 0.77
Unusual association of seronegative, nonparaneoplastic limbic encephalitis and relapsing polychondritis in a patient with history of thymectomy for myasthenia: a case study. J Neurol (2010) 0.77
Update on paraneoplastic neurologic disorders. Oncologist (2010) 0.77
Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis. Epilepsy Behav Case Rep (2014) 0.77
Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis. J Neurol (2008) 0.76
Thyroid antibodies, autoimmunity and cognitive decline: is there a population-based link? Dement Geriatr Cogn Dis Extra (2014) 0.76
Cell-mediated immune responses in paraneoplastic neurological syndromes. Clin Dev Immunol (2013) 0.76
Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis. J Neuroimmunol (2015) 0.76
Image of the month. FDG-PET in paraneoplastic limbic encephalitis. Eur J Nucl Med Mol Imaging (2008) 0.75
A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody. Ann Indian Acad Neurol (2016) 0.75
Paraneoplastic neurological syndrome as initial presentation of pulmonary adenocarcinoma. BMJ Case Rep (2012) 0.75
A case of limbic encephalitis presenting as a paraneoplastic manifestation of limited stage small cell lung cancer: a case report. J Med Case Rep (2010) 0.75
A patient with an acute confusional state. BMJ Case Rep (2010) 0.75
Hyponatraemia caused by LGI1-associated limbic encephalitis. NDT Plus (2011) 0.75
Paraneoplastic limbic encephalitis as a cause of new onset of seizures in a patient with non-small cell lung carcinoma: a case report. J Med Case Rep (2008) 0.75
Prognostic effect of early treatment of paraneoplastic limbic encephalitis in a patient with small-cell lung cancer. Curr Oncol (2012) 0.75
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. BMJ Case Rep (2009) 0.75
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61
Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol (1983) 5.98
Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (1982) 4.40
A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med (1999) 3.58
Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology (2010) 3.40
HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell (1991) 3.33
Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21
Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11
Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology (1992) 3.11
Distribution of brain metastases. Arch Neurol (1988) 3.11
Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol (1978) 3.08
Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology (2008) 2.85
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology (2012) 2.78
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Radiation-induced dementia in patients cured of brain metastases. Neurology (1989) 2.59
Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis. Ann Neurol (1990) 2.58
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology (2007) 2.55
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med (1990) 2.54
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry (2006) 2.52
Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35
Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol (1974) 2.33
Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology (2011) 2.32
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27
Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology (2006) 2.25
Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry (2008) 2.16
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol (2001) 2.15
Insights into antibody-associated encephalitis--Bickerstaff's 1950's papers revisited. J Neurol Sci (2013) 2.13
Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology (1979) 2.13
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry (2007) 2.10
Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05
Spinal-fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med (1967) 1.93
Intracranial metastases from systemic cancer. Adv Neurol (1978) 1.92
Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol (1999) 1.91
The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91
NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology (2010) 1.88
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86
Motor neuron syndromes in cancer patients. Ann Neurol (1997) 1.82
Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology (2004) 1.81
MRI changes in intracranial hypotension. Neurology (1993) 1.80
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. Am J Clin Pathol (1984) 1.79
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology (2003) 1.79
Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis. Neurology (2010) 1.73
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Status epilepticus with neuron-reactive serum antibodies: response to plasma exchange. Neurology (2000) 1.72
GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology (2011) 1.71
Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70
Radiation therapy for brain metastases. Ann Neurol (1980) 1.68
Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol (1980) 1.68
Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology (2006) 1.67
Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol (2006) 1.67
Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology (1988) 1.66
Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neurol (1968) 1.66
Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology (1990) 1.65
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology (2011) 1.64
Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol (1988) 1.63
Metastasis to the base of the skull: clinical findings in 43 patients. Neurology (1981) 1.61
Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59
Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol (1977) 1.58
Steroid myopathy in cancer patients. Neurology (1997) 1.57
Ataxia in epidural spinal cord compression. Neurology (1992) 1.55
Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology (1994) 1.54
Neurologic complications of carcinoid. Neurology (1986) 1.54
Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies. Eur J Neurol (2007) 1.51
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry (2008) 1.46
Chorea as a paraneoplastic complication of Hodgkin's disease. J Neurooncol (1998) 1.44
Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol (1979) 1.42
Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology (1995) 1.41
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1991) 1.41
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39
[Analysis of the neurologic consultations in an oncologic hospital: contributions of neuro-oncology]. Neurologia (1999) 1.38